Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-013608
Filing Date
2017-11-20
Accepted
2017-11-20 15:55:58
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 804930
2 ex31-1.htm EX-31.1 8604
3 ex31-2.htm EX-31.2 8540
4 ex32-1.htm EX-32.1 5534
5 ex32-2.htm EX-32.2 5259
  Complete submission text file 0001493152-17-013608.txt   4025129

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20170930.xml EX-101.INS 520287
7 XBRL SCHEMA FILE obmp-20170930.xsd EX-101.SCH 41403
8 XBRL CALCULATION FILE obmp-20170930_cal.xml EX-101.CAL 57512
9 XBRL DEFINITION FILE obmp-20170930_def.xml EX-101.DEF 206914
10 XBRL LABEL FILE obmp-20170930_lab.xml EX-101.LAB 348649
11 XBRL PRESENTATION FILE obmp-20170930_pre.xml EX-101.PRE 283956
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

EIN.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 171213720
SIC: 2834 Pharmaceutical Preparations